PharmaMar Presents New Data on Plitidepsin, Lurbinectedin Therapies to Treat Ovarian Cancer, Multiple Myeloma
News
Plitidepsin and lurbinectedin, two drugs advancing in clinical studies for the treatment of ovarian cancer and other malignancies, were the focus of two PharmaMar presentations at the April 1-5 American Association of Cancer Research (AACR) ... Read more